Gilles de la Tourette's syndrome

Canadian Journal of Neurological Sciences

Volumn 30, Issue SUPPL. 1, 2003, Pages

  Faridi, Kia ^a   Suchowersky, Oksana ^b,c  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c Health Sciences Centre Calgary   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; DRONABINOL; FLUNARIZINE; HALOPERIDOL; NALOXONE; NEUROLEPTIC AGENT; NICOTINE; OLANZAPINE; OPIATE DERIVATIVE; PERGOLIDE; PIMOZIDE; RISPERIDONE; TETRABENAZINE;

ATTENTION DEFICIT DISORDER; AUTOSOMAL DOMINANT INHERITANCE; BEHAVIOR DISORDER; COMORBIDITY; DEPRESSION; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DROWSINESS; ERECTILE DYSFUNCTION; GILLES DE LA TOURETTE SYNDROME; HOME; HUMAN; MOTOR DYSFUNCTION; MULTIFACTORIAL INHERITANCE; OBSESSIVE COMPULSIVE DISORDER; PIGMENT DISORDER; PREVALENCE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; REVIEW; SEDATION; SIDE EFFECT; TIC; TREATMENT INDICATION; WEIGHT GAIN; WORK;

EID: 0037350014     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0317167100003267     Document Type: Review

References (73)

1. Marcus D, Kurlan R. Tics and its disorders. Neurol Clin 2001; 19: 735-758.
2. Leckman JF, Walker DE, Cohen DJ. Premonitory urges in Tourette's syndrome. Am J Psych 1993; 150:98-102.
3. Bruun RD, Budman CL. The course and prognosis of Tourette's Syndrome. Neurol Clin 1997; 15:291-298.
4. Peterson BS. Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome. J Clin Psych 1996; 57(Suppl 9):24-34.
5. Leckman JF, Zhang H, Vitale A, et al. Course of tic severity in Tourette's syndrome: the first two decades. Pediatrics 1998; 102:14-19.
6. de Groot CM, Bornstein RA, Spetie L, Burriss B. The course of tics in Tourette's syndrome: a 5-year follow-up study. Ann Clin Psych 1994; 6:227-233.
7. Robertson MM. Tourette's syndrome, associated conditions and the complexities of treatment. Brain 2000; 123:425-462.
8. Baron-Cohen S, Scahill VL, Izaguirre J, et al. The prevalence of Gilles de la Tourette's syndrome in children and adolescents with autism: a large scale study. Psychol Med 1999; 29:1151-1159.
9. Coffey BJ, Miguel EC, Biederman J, et al. Tourette's disorder with and without obsessive-compulsive disorder in adults: are they different? J Nerv Mental Disease 1998; 186:201-206.
10. Cath DC, Spinhoven P, van de Wetering BJ, et al. The relationship between types and severity of repetitive behaviours in Gilles de la Tourette's disorder and obsessive-compulsive disorder. J Clin Psych 2000; 61:505-513.
11. Towbin KE, Riddle MA. Attention deficit hyperactivity disorder. In: Hurla R, (Ed). Handbook of Tourette's Syndrome and Related Tic and Behavioral Disorders. New York: Marcel Dekker, 1993; 89-109.
12. Apter A, Pauls DL, Bleich A, et al. An epidemiologic study of Gilles de la Tourette's syndrome in Israel. Arch Gen Psych 1993; 50: 734-738.
13. Knell ER, Comings DE. Tourette's syndrome and attention-deficit hyperactivity disorder: evidence for a genetic relationship. J Clin Psych 1993; 54:331-337.
14. Pauls DL, Leckman JF, Cohen DJ. Familial relationship between Gilles de la Tourette's syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering. J Am Acad Child Adolesc Psychiatry 1993; 32:1044-1056.
15. Spencer T, Biederman J, Harding M, et al. Disentangling the overlap between Tourette's disorder and ADHD. J Child Psychol Psychiatry Allied Disc 1998; 39:1037-1044.
16. Kurlan R, Como PG, Miller B, et al. The behavioural spectrum of tic disorders. Neurology 2002; 59:414-420.
17. Voderholzer U, Muller N, Haag C, Riemann D, Straube A. Periodic limb movements during sleep are a frequent finding in Gilles de la Tourette's syndrome. J Neurol 1997; 244:521-526.
18. Abwender DA, Trinidad KS, Jones KR, et al. Features resembling Tourette's syndrome in developmental stutterers. Brain Lang 1998; 62:455-464.
19. Abwender DA, Como PG, Kurlan R, et al. School problems in Tourette's syndrome. Arch Neurol 1996; 53:509-511.
20. Carter AS, O'Donnell DA, Schultz RT, et al. Social and emotional adjustment in children affected with Gilles de la Tourette's syndrome: associations with ADHD and family functioning. Attention Deficit Hyperactivity Disorder. J Child Psychol Psychiatry 2000; 41:215-223.
21. Bawden HN, Stokes A, Camfield CS, Camfield PR, Salisbury S. Peer relationship problems in children with Tourette's disorder or diabetes mellitus. J Child Psychol Psychiatry 1998; 39:663-668.
22. Thibert AL, Day HI, Sandor P. Self-concept and self-consciousness in adults with Tourette's syndrome. Can J Psychiatry 1995; 40: 35-39.
23. Friedrich S, Morgan SB, Devine C. Children's attitudes and behavioural intentions toward a peer with Tourette's syndrome. J Pediatr Psychol 1996; 21:307-319.
24. Champion LM, Fulton WA, Shady GA. Tourette's syndrome and social functioning in a Canadian population. Neurosci Behav Rev 1988; 12:255-257.
25. Costello EJ, Angold A, Burns BJ, et al. The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders. Arch Gen Psych 1996; 53:1129-1136.
26. Hornsey H, Banerjee S. The prevalence of Tourette's syndrome in 13-14 year olds in mainstream schools. J Child Psychol Psychiatry 2001; 42(8):1035-1039.
27. Price RA, Kidd KK, Cohen DJ, Pauls DL, Leckman JF. A twin study of Tourette's syndrome. Arch Gen Psych 1985; 42:815-820.
28. Hasstedt SJ, Leppert M, Filloux F, van de Wetering BJ, McMahon WM. Intermediate inheritance of Tourette's syndrome, assuming assortative mating. Am J Hum Genet 1995; 57:682-689.
29. Walkup JT, LaBuda MC, Singer HS, et al. Family study and segregation analysis of Tourette's syndrome: evidence for a mixed model of inheritance. Am J Hum Genet 1996; 59:684-693.
30. Seuchter SA, Hebebrand J, Klug B, et al. Complex segregation analysis of families ascertained through Gilles de la Tourette's syndrome. Genet Epidemiol 2000; 18:33-47.
31. Kurlan R, Eapen V, Stern J, McDermott MP, Robertson MM. Bilineal transmission in Tourette's syndrome families. Neurol 1994; 44(12):2336-2342.
32. McMahon WM, van de Wetering BJ, Filloux F, et al. Bilineal transmission and phenotypic variation of Tourette's disorder in a large pedigree. J Am Acad Child Adolesc Psychiatry 1996; 35:672-680.
33. Lichter DG, Dmochowski J, Jackson LA, Trinidad KS. Influence of family history on clinical expression of Tourette's syndrome. Neurology 1999; 52:308-316.
34. Lichter DG, Jackson LA, Schachter M. Clinical evidence of genomic imprinting in Tourette's syndrome. Neurology 1995; 45:924-928.
35. Eapen V, O'Neill J, Gurling HM, Robertson MM. Sex of parent transmission effect in Tourette's syndrome: evidence for earlier age at onset in maternally transmitted cases suggests a genomic imprinting effect. Neurology 1997; 48:934-937.
36. Furtado S, Suchowersky O. Investigation of the potential role of genetic imprinting in Gilles de la Tourette's syndrome. Am J Med Genet 1994; 51:51-54.
37. Brett PM, Curtis D, Robertson MM, Gurling HM. The genetic susceptibility to Gilles de la Tourette's syndrome in a large multiple affected British kindred: linkage analysis excludes a role for the genes coding for dopamine D1, D2, D3, D4, D5 receptors, dopamine beta hydroxylase, tyrosinase, and tyrosine hydroxylase. Biol Psychiatry 1995; 37:533-540.
38. Moriarty J, Varma AR, Stevens J, et al. A volumetric MRI study of Gilles de la Tourette's syndrome. Neurology 1997; 49:410-415.
39. Castellanos FX, Giedd JN, Hamburger SD, Marsh WL, Rapoport JL. Brain morphometry in Tourette's syndrome: the influence of comorbid attention-deficit/hyperactivity disorder. Neurology 1996; 47:1581-1583.
40. Hyde TM, Stacey ME, Coppola R, et al. Cerebral morphometric abnormalities in Tourette's syndrome: a quantitative MRI study of monozygotic twins. Neurology 1995; 45:1176-1182.
41. Baumgardner TL, Singer HS, Denckla MB, et al. Corpus callosum morphology in children with Tourette's syndrome and attention deficit hyperactivity disorder. Neurology 1996; 47:477-482.
42. Peterson BS, Leckman JF, Duncan JS, et al. Corpus callosum morphology from magnetic resonance images in Tourette's syndrome. Psych Res 1994; 55:85-99.
43. Mostofsky SH, Wendlandt J, Cutting L, Denckla MB, Singer HS. Corpus callosum measurements in girls with Tourette's syndrome. Neurol 1999; 53:1345-1347.
44. Zimmerman AM, Abrams MT, Giuliano JD, Denckla MB, Singer HS. Subcortical volumes in girls with Tourette's syndrome: support for a gender effect. Neurology 2000; 54:2224-2229.
45. Moriarty J, Costa DC, Schmitz B, et al. Brain perfusion abnormalities in Gilles de la Tourette's syndrome. Br J Psych 1995; 167:249-254.
46. Riddle MA, Rasmusson AM, Woods SW, et al. SPECT imaging of cerebral blood flow in Tourette's syndrome. In: Chase TN, Friedhoff AJ, and Cohen DJ, (Eds). Advances in Neurology Vol 58. Tourette's Syndrome: Genetics, Neurobiology, and Treatment. Raven Press, 1992.
47. Klieger PS, Fett KA, Dimitsopulos T, Karlan R. Asymmetry of basal ganglia perfusion in Tourette's syndrome shown by technetium-99m-HMPAO SPECT. J Nuclear Med 1997; 38:188-191.
48. Lampreave JL, Molina V, Mardomingo MJ, et al. Technetium-99m-HMPAO in Tourette's syndrome on neuroleptic therapy and after withdrawal. J Nuclear Med 1998; 39:624-628.
49. Braun AR, Stoetter B, Randolph C, et al. The functional neuroanatomy of Tourette's syndrome: an FDG-PET study. I. Regional changes in cerebral glucose metabolism differentiating patients and controls. Neuropsychopharmacology 1993; 9:277-291.
50. Braun AR, Randolph C, Stoetter B, et al. The functional neuroanatomy of Tourette's syndrome: an FDG-PET Study. II: Relationships between regional cerebral metabolism and associated behavioral and cognitive features of the illness. Neuropsychopharmacology 1995; 13:151-168.
51. Biswal B, Ulmer JL, Krippendorf RL, et al. Abnormal cerebral activation associated with a motor task in Tourette's syndrome. Am J Neuroradiology 1998; 19:1509-1512.
52. Peterson BS, Skudlarski P, Anderson AW, et al. A functional magnetic resonance imaging study of tic suppression in Tourette's syndrome. Arch Gen Psych 1998; 55:326-333.
53. Stern E, Silbersweig DA, Chee KY, et al. A functional neuroanatomy of tics in Tourette's syndrome. Arch Gen Psych 2000; 57:741-748.
54. Bergin A, Waranch HR, Brown J, Carson K, Singer HS. Relaxation therapy in Tourette's syndrome: a pilot study. Pediatr Neurol 1998; 18:136-142.
55. Evers RA, van de Wetering BJ. A treatment model for motor tics based on a specific tension-reduction technique. J Behav Ther Exp Psychiatry 1994; 25:255-260.
56. Shapiro AK, Shapiro E, Eisenbraft GJ. Treatment of Gilles de la Tourette's syndrome with pimozide. Am J Psychiatry 1983; 140:1183-1186.
57. Fulop G, Phillips RA, Shapiro AK, et al. ECG changes during haloperidol and pimozide treatment of Tourette's disorder. Am J Psychiatry 1987; 144:673-675.
58. Bruun RD, Budman CL. Risperidone as a treatment for Tourette's syndrome. J Clin Psych 1996; 57:29-31.
59. Robertson MM, Scull DA, Eapen V, Trimble MR. Risperidone in the treatment of Tourette's syndrome: a retrospective case note study. J Psychopharmacol 1996; 10:317-320.
60. Gaffney GR, Gary R, Perry JP, et al. Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome; statistical data included. J Am Acad Child Adolesc Psychiatry 2002; 41:330-336.
61. Dion Y, Annabel L, Sandor P, Chouinard G. Risperidone in the treatment of Tourette's syndrome: a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2002; 22(1):31-39.
62. Stamenkovic M, Schindler SD, Aschauer HN, et al. Effective open-label treatment of Tourette's disorder with olanzapine. Int Clin Psychopharmacol 2000; 15:23-28.
63. Jankovic J, Glaze DG, Frost JD. Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome. Neurology 1984; 34:688-692.
64. Gilbert DL, Sethuraman G, Sine L, Peters S, Sallee FR. Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial. Neurology 2000; 54:1310-1315.
65. Micheli F, Gatto M, Lekhuniec E, et al. Treatment of Tourette's syndrome with calcium antagonists. Clin Neuropharmacol 1990; 13:77-83.
66. Sandyk R. The effects of naloxone in Tourette's syndrome. Ann Neurol 1985; 18:367-368.
67. Muller-Vahl KR, Schneider U, Kolbe H, Emrich HM. Treatment of Tourette's syndrome with delta-9-tetrahydrocannabinol. Am J Psychiatry 1999; 156:495.
68. Sanberg PR, Silver AA, Shytle RD, et al. Nicotine for the treatment of Tourette's syndrome. Pharmacol Ther 1997; 74:21-25.
69. Gadow KD, Nolan E, Sprafkin J, Sverd J. School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment. J Dev Behav Pediatr 1995; 16:167-176.
70. Castellanos FX, Giedd JN, Elia J, et al. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose. J Am Acad Child Adolesc Psychiatry 1997; 36:589-596.
71. Tourette's Study Group. Treatment of ADHD in children with tics. Neurology 2002; 58:527-536.
72. Singer HS, Brown J, Quaskey S, et al. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics 1995; 95:74-81.
73. Scahill L, Riddle MA, King RA, et al. Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: a double-blind placebo-controlled study. J Child Adolesc Psychopharmacol 1997; 7:75-85.